SEKTAYOS

Serial Number 97499202
734

Registration Progress

Application Filed
Jul 12, 2022
Under Examination
Nov 15, 2022
Approved for Publication
Sep 20, 2022
Published for Opposition
Sep 20, 2022
Registered

Attorney Assistance

Statement of Use Due - Extension 5 Granted
Due: Nov 15, 2025 130 days
Statement of Use required (all extensions used)

Basic Information

Serial Number
97499202
Deadline
November 15, 2025
Description
Statement of Use
Filing Date
July 12, 2022
Published for Opposition
September 20, 2022
Drawing Code
3

Status Summary

Current Status
Active
Status Code
734
Status Date
May 15, 2025
Application
Pending
Classes
005

Rights Holder

Intercept Pharmaceuticals, Inc.

03
Address
305 Madison Avenue
Morristown, NJ 07960

Ownership History

Intercept Pharmaceuticals, Inc.

Original Applicant
03
Morristown, NJ

Intercept Pharmaceuticals, Inc.

Owner at Publication
03
Morristown, NJ

Legal Representation

Attorney
Jennifer Sheehan Anderson

USPTO Deadlines

Next Deadline
130 days remaining
Statement of Use Due - Extension 5 Granted
Due Date
November 15, 2025

Application History

32 events
Date Code Type Description
May 16, 2025 IULN O ITU LETTER MAILED, NO RESPONSE REQUIRED
May 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 15, 2025 EEXT I SOU TEAS EXTENSION RECEIVED
May 15, 2025 EEXT I SOU TEAS EXTENSION RECEIVED
May 15, 2025 EX5G S SOU EXTENSION 5 GRANTED
May 15, 2025 EXT5 S SOU EXTENSION 5 FILED
Dec 26, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 26, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 26, 2024 EX4G S SOU EXTENSION 4 GRANTED
Nov 13, 2024 EXT4 S SOU EXTENSION 4 FILED
Nov 13, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
May 7, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 6, 2024 EXT3 S SOU EXTENSION 3 FILED
May 6, 2024 EX3G S SOU EXTENSION 3 GRANTED
May 6, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 28, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 26, 2023 EX2G S SOU EXTENSION 2 GRANTED
Oct 26, 2023 EXT2 S SOU EXTENSION 2 FILED
Oct 26, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
May 16, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 12, 2023 EX1G S SOU EXTENSION 1 GRANTED
May 12, 2023 EXT1 S SOU EXTENSION 1 FILED
May 12, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 15, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 20, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 20, 2022 PUBO A PUBLISHED FOR OPPOSITION
Aug 31, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 15, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 4, 2022 DOCK D ASSIGNED TO EXAMINER
Aug 2, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 1, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 15, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of liver diseases, disorders and conditions

Additional Information

Design Mark
The mark consists of the word "SEKTAYOS" with a two-tone arc with six rays protruding from the top center of the arc and a round notch in the bottom center of the arc over the letters "YOS".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005